Monsenso A/S (CPH:MONSO)
Denmark
· Delayed Price · Currency is DKK 0.130
+0.010 (8.33%)
At close: Mar 6, 2026
Monsenso Revenue
In the year 2025, Monsenso had annual revenue of 8.91M DKK, down -20.22%. Monsenso had revenue of 5.17M in the half year ending June 30, 2025, with 17.17% growth.
Revenue
8.91M
Revenue Growth
-20.22%
P/S Ratio
1.09
Revenue / Employee
742.25K
Employees
12
Market Cap
9.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.91M | -2.26M | -20.22% |
| Dec 31, 2024 | 11.17M | 1.54M | 16.01% |
| Dec 31, 2023 | 9.62M | 3.41M | 54.90% |
| Dec 31, 2022 | 6.21M | -930.00K | -13.02% |
| Dec 31, 2021 | 7.14M | -1.92M | -21.19% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Genmab | 23.66B |
| Coloplast | 27.89B |
| ALK-Abelló | 6.31B |
| BioPorto | 36.56M |
| ViroGates | 8.11M |
| Scandinavian Medical Solutions | 245.44M |
| Stenocare | 7.02M |